Vaccine maker Moderna's finances began to fall as quickly as they rose. That's because most Americans have refused another COVID-19 booster shot. The pharmaceutical company, whose pioneering mRNA vaccines transformed it from a small startup into a biotech giant valued at more than $100 billion in just a few years, announced that it would have to wait until the third quarter of last year as most Americans refused to get another COVID-19 booster shot. It reported losses of $3.6 billion. .
Related Posts
Add A Comment